2021 American Transplant Congress
Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients
Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: A high number of comorbidities associated with the severity of the disease caused by SARS-CoV-2 (COVID-19) has been reported, such as systemic arterial hypertension…2021 American Transplant Congress
Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant
Mount Sinai Hospital, New York, NY
*Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…2021 American Transplant Congress
The Impact of Diabetes on Young Transplant Recipients: An American Perspective
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…2020 American Transplant Congress
Early Worsening of Diabetic Retinopathy after Pancreas and Kidney Transplantation: Myth or Reality?
*Purpose: Type-1 diabetic pancreas and kidney transplant candidates frequently suffer from advanced diabetic retinopathy. Early worsening of diabetic retinopathy (EWDR) attributed to sudden glucose normalization…2020 American Transplant Congress
HLA Cw12 in Kidney Transplant Recipients is a Novel Risk Factor for the Development of Post-Transplantation Diabetes: A Single-Centre Retrospective Study
*Purpose: Counselling kidney transplant candidates for their personalised risk of developing post-transplantation diabetes mellitus (PTDM) requires an understanding of risk factors. While some risk factors…2020 American Transplant Congress
Functional Changes in Metabolic and Malignancy Associated Bacterial Genes in the Post Transplant Intestinal Microbiome
*Purpose: Long-term survival of liver transplant (LT) recipients is affected by metabolic and malignant complications. The aim of our study was to examine changes in…2020 American Transplant Congress
Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?
Mayo Clinic Jacksonville, Jacksonville, FL
*Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the…2020 American Transplant Congress
Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population
*Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…2020 American Transplant Congress
GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity
University of Virginia, Charlottesville, VA
*Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…2020 American Transplant Congress
Diabetes Burnout: An Under-Recognized Risk-Factor in Post-Transplant Care Management
Medical University of South Carolina, Charleston, SC
*Purpose: One-third of dialysis patients will have spontaneous glycemic control improvement, necessitating discontinuation of antihyperglycemic therapy, termed diabetes burnout. The aim of this study was…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »